Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Christopher-Stine

Showing results (121-130 of 208) with videos related to

Pageof 21
Sort By:
ACR Open Rheumatology|October 6, 2024
The Relationship Between Anti-Cell Division Cycle and Apoptosis Regulator 1 Autoantibodies, Anti-Sp4 Autoantibodies, and Cancer in Anti-Transcription Intermediary Factor 1γ-Positive DermatomyositisChristopher A Mecoli, David Fiorentino, Jemima Albayda, et al.
Annals of the Rheumatic Diseases|August 9, 2015
PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndromeDavid F Fiorentino, Matthew Presby, Alan N Baer, et al.
Seminars in Arthritis and Rheumatism|March 5, 2026
Clinical characteristics and risk factors associated with objective flares in patients with dermatomyositisDidem Saygin, Xing Yao Wang, Kathryn C Fitzgerald, et al.
Clinical and Experimental Rheumatology|May 11, 2019
Efficacy and adverse effects of methotrexate compared with azathioprine in the antisynthetase syndromeMaria Casal-Dominguez, Iago Pinal-Fernandez, Julio Huapaya, et al.
Clinical Rheumatology|April 14, 2021
Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositisSara E Sabbagh, Iago Pinal-Fernandez, Maria Casal-Dominguez, et al.
Rheumatology (Oxford, England)|March 25, 2017
A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodiesIago Pinal-Fernandez, Maria Casal-Dominguez, Julio A Huapaya, et al.
Respiratory Medicine|April 10, 2019
The ILD-GAP risk prediction model performs poorly in myositis-associated interstitial lung diseaseRebeccah M Brusca, Iago Pinal-Fernandez, Kevin Psoter, et al.
Clinical Rheumatology|April 9, 2017
"Hiker's feet": a novel cutaneous finding in the inflammatory myopathiesJacob T Cox, David M Gullotti, Christopher A Mecoli, et al.
Rheumatology (Oxford, England)|January 19, 2017
More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathyEleni Tiniakou, Iago Pinal-Fernandez, Thomas E Lloyd, et al.
Clinical and Experimental Rheumatology|January 9, 2026
Prevalence and early detection of myocarditis in idiopathic inflammatory myopathies: a prospective single-centre studyCody R Calhoun, Caoilfhionn M Connolly, Jemima Albayda, et al.
Pageof 21

Showing results (121-130 of 208) with videos related to

Sort By:
Pageof 21
ACR Open Rheumatology|October 6, 2024
The Relationship Between Anti-Cell Division Cycle and Apoptosis Regulator 1 Autoantibodies, Anti-Sp4 Autoantibodies, and Cancer in Anti-Transcription Intermediary Factor 1γ-Positive DermatomyositisChristopher A Mecoli, David Fiorentino, Jemima Albayda, et al.
Annals of the Rheumatic Diseases|August 9, 2015
PUF60: a prominent new target of the autoimmune response in dermatomyositis and Sjögren's syndromeDavid F Fiorentino, Matthew Presby, Alan N Baer, et al.
Seminars in Arthritis and Rheumatism|March 5, 2026
Clinical characteristics and risk factors associated with objective flares in patients with dermatomyositisDidem Saygin, Xing Yao Wang, Kathryn C Fitzgerald, et al.
Clinical and Experimental Rheumatology|May 11, 2019
Efficacy and adverse effects of methotrexate compared with azathioprine in the antisynthetase syndromeMaria Casal-Dominguez, Iago Pinal-Fernandez, Julio Huapaya, et al.
Clinical Rheumatology|April 14, 2021
Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositisSara E Sabbagh, Iago Pinal-Fernandez, Maria Casal-Dominguez, et al.
Rheumatology (Oxford, England)|March 25, 2017
A longitudinal cohort study of the anti-synthetase syndrome: increased severity of interstitial lung disease in black patients and patients with anti-PL7 and anti-PL12 autoantibodiesIago Pinal-Fernandez, Maria Casal-Dominguez, Julio A Huapaya, et al.
Respiratory Medicine|April 10, 2019
The ILD-GAP risk prediction model performs poorly in myositis-associated interstitial lung diseaseRebeccah M Brusca, Iago Pinal-Fernandez, Kevin Psoter, et al.
Clinical Rheumatology|April 9, 2017
"Hiker's feet": a novel cutaneous finding in the inflammatory myopathiesJacob T Cox, David M Gullotti, Christopher A Mecoli, et al.
Rheumatology (Oxford, England)|January 19, 2017
More severe disease and slower recovery in younger patients with anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathyEleni Tiniakou, Iago Pinal-Fernandez, Thomas E Lloyd, et al.
Clinical and Experimental Rheumatology|January 9, 2026
Prevalence and early detection of myocarditis in idiopathic inflammatory myopathies: a prospective single-centre studyCody R Calhoun, Caoilfhionn M Connolly, Jemima Albayda, et al.
Pageof 21